Non-exclusive license allows for development by Pfizer to utilize Matrix-M® for up to two disease areas with its products Provides Novavax with an upfront payment of $30 million with the potential for up to another $500 million in development and sales milestones. In addition to milestone...
Hence then, the article about novavax announces entering into a license agreement with pfizer was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Novavax Announces Entering into a License Agreement with Pfizer )
Also on site :
- Rangers’ Cody Bradford Targeting Return In May From Elbow Surgery
- Trump discloses ‘private message’ from Macron
- Trump mocks Macron after Gaza ‘peace board’ snub